| Roche Pharma (Schweiz) AG - Hemlibra 105mg/0.7ml, Injektionslösung |
| 66694 | | 03 | | Hemlibra 105mg/0.7ml | | Injektionslösung | | B02BX06 | | Emicizumab | | 06.11.2018 | | |
|
| Composition |
| emicizumabum 105 mg, histidinum, acidum asparticum, argininum, poloxamerum 188, aqua ad iniectabile ad solutionem pro 0.7 ml. |
| Packungsbestandteile |
| Injection solution | | | | | | | | Active Agent | Dose |
|---|
| Emicizumabum | 105mg / 0.7ml |
| | BAG: Active Agent | Dose |
|---|
| Emicizumabum | 105 mg |
| | | | Inactive agents | Dose |
|---|
| Aspartic Acid | | | Arginine | | | Histidine | | | Poloxamer | 188 |
| |
|
| Package number | Package Size | EFP | CP | Category | SL | Out of trade (MedRef) |
|---|
| 003 | | 5698.16 | 5887.35 | A | SL | No |
|
